Nektar Says Eli Lilly Botched Autoimmune Drug Trials
By Ayden Crosby · August 7, 2023, 7:47 PM EDT
Nektar Therapeutics is accusing Eli Lilly of butchering and delaying clinical trials for a new autoimmune-disease drug the two companies agreed to develop together, claiming the pharma giant ruined the drug's...
To view the full article, register now.